Myeloma XII clinical trial samples
http://www.isrctn.com/ISRCTN10038996
Samples collected from myeloma patients at first relapse registered into the Myeloma XII trial, and sent to the following central labs: 1. Central immunology laboratory, University of Birmingham - peripheral clotted blood and urine collected at various timepoints throughout the trial; 2. Haematology Malignancy Diagnostic Service (HMDS) laboratory, St James's University Hospital, Leeds - bone marrow aspirate, collected at various timepoints throughout the trial; 3. Leeds Institute of Cancer and Pathology (LICAP), University of Leeds - peripheral blood, serum, and bone marrow aspirate collected at various timepoints throughout the trial.
Existing samples:
- Multiple myeloma (disorder)
Bespoke collection capabilities:
- Multiple myeloma (disorder)
Contact Information
- Email:
- ctru-myelomaxii@leeds.ac.uk
- Address:
-
Clinical Trials Research Unit
Leeds Institute of Clinical Trials Research
University of Leeds
Leeds
West Yorkshire
LS2 9JT
England
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2018 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |